The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 28, 2021

Filed:

Apr. 07, 2017
Applicant:

Amgen Inc., Thousand Oaks, CA (US);

Inventors:

Scott R. Gibson, Granada Hills, CA (US);

Sheldon B. Moberg, Thousand Oaks, CA (US);

Basel Hasan Taha, Westlake Village, CA (US);

Margaux Frances Boyaval, Newbury Park, CA (US);

Mark A. Destefano, Collegeville, PA (US);

Lawton Laurence, Phoenixville, PA (US);

John C. Love, San Diego, CA (US);

Ian B. Hanson, Wayne, PA (US);

Paul F. Bente, IV, Wayne, PA (US);

Matthew J. Clemente, Carmel, IN (US);

Antonio Ubach, Tucson, AZ (US);

Rajan Ramaswamy, San Diego, CA (US);

Daniel S. Codd, Escondido, CA (US);

Scott Beaver, San Marcos, CA (US);

Kevin L. Bokelman, San Diego, CA (US);

Ian P. Dardani, Radnor, PA (US);

Sean M. O'connor, West Chester, PA (US);

Danielle Feldman, Philadelphia, PA (US);

Assignee:

AMGEN INC., Thousand Oaks, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61M 5/145 (2006.01); A61M 5/142 (2006.01); A61M 5/158 (2006.01);
U.S. Cl.
CPC ...
A61M 5/14566 (2013.01); A61M 5/14248 (2013.01); A61M 5/158 (2013.01); A61M 2005/14252 (2013.01); A61M 2005/1585 (2013.01); A61M 2202/0441 (2013.01); A61M 2202/0447 (2013.01); A61M 2205/103 (2013.01); A61M 2205/12 (2013.01); A61M 2205/3368 (2013.01); A61M 2205/3553 (2013.01); A61M 2205/3561 (2013.01); A61M 2205/3584 (2013.01); A61M 2205/3592 (2013.01); A61M 2205/36 (2013.01); A61M 2205/8206 (2013.01);
Abstract

Disclosed herein is a wearable drug delivery device including a container filled at least partially with a drug including at least one of a PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) specific antibody, a granulocyte colony-stimulating factor CSF), a sclerostin antibody, or a calcitonin gene-related peptide (CGRP) antibody. The wearable drug delivery device includes a needle and an insertion mechanism configured to insert the needle into a patient. A fluid pathway connector defines a sterile fluid flowpath between the container and the insertion mechanism. A cannula initially disposed about the needle is included.


Find Patent Forward Citations

Loading…